Intellia Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	988	949	2,144	2,468	6,498	2,574
Market Cap Growth	20.53%	-55.75%	-13.15%	-62.02%	152.49%	375.34%
Enterprise Value	568	275	1,457	1,845	5,706	2,291
Last Close Price	8.33	9.29	24.19	28.48	88.62	44.11
PS Ratio	23.09	20.52	75.27	57.06	266.22	60.59
PB Ratio	1.77	1.36	2.60	2.41	8.46	6.67
P/TBV Ratio	1.77	1.36	2.60	2.41	8.46	6.67
EV/Sales Ratio	13.46	5.95	51.17	42.65	233.76	53.94
EV/FCF Ratio	-1.85	-	-	-	-	-
Debt / Equity Ratio	0.13	0.24	0.11	0.11	0.07	0.08
Asset Turnover	0.06	0.05	0.03	0.04	0.03	0.12
Quick Ratio	5.57	5.50	8.23	9.45	5.97	9.33
Current Ratio	6.21	5.77	8.66	9.62	6.11	9.60
Return on Equity (ROE)	-52.11%	-54.01%	-42.10%	-41.67%	-34.19%	-33.69%
Return on Assets (ROA)	-28.51%	-26.80%	-22.83%	-20.35%	-16.99%	-16.89%
Return on Capital Employed (ROCE)	-57.60%	-49.50%	-43.50%	-32.90%	-22.90%	-22.30%
Earnings Yield	-33.57%	-43.70%	-17.62%	-15.95%	-3.04%	-3.82%
FCF Yield	-31.07%	-29.87%	-14.95%	-11.66%	-2.70%	-1.52%
Buyback Yield / Dilution	-9.22%	-11.35%	-15.33%	-8.57%	-26.63%	-18.50%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.